Cargando…

Muscular weakness and muscle wasting in the critically ill

BACKGROUND: Muscular weakness and/or muscle wasting is recognized as a key medical problem in critically ill patients on intensive care units (ICUs) worldwide. METHODS AND RESULTS: Intensive care unit‐acquired weakness (ICUAW) results from various diseases leading to critical illness and is observed...

Descripción completa

Detalles Bibliográficos
Autores principales: Schefold, Joerg C., Wollersheim, Tobias, Grunow, Julius J., Luedi, Markus M., Z'Graggen, Werner J., Weber‐Carstens, Steffen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749542/
https://www.ncbi.nlm.nih.gov/pubmed/32893974
http://dx.doi.org/10.1002/jcsm.12620
_version_ 1783625323953258496
author Schefold, Joerg C.
Wollersheim, Tobias
Grunow, Julius J.
Luedi, Markus M.
Z'Graggen, Werner J.
Weber‐Carstens, Steffen
author_facet Schefold, Joerg C.
Wollersheim, Tobias
Grunow, Julius J.
Luedi, Markus M.
Z'Graggen, Werner J.
Weber‐Carstens, Steffen
author_sort Schefold, Joerg C.
collection PubMed
description BACKGROUND: Muscular weakness and/or muscle wasting is recognized as a key medical problem in critically ill patients on intensive care units (ICUs) worldwide. METHODS AND RESULTS: Intensive care unit‐acquired weakness (ICUAW) results from various diseases leading to critical illness and is observed in about 40% [1080/2686 patients, 95% confidence interval (CI): 38–42%] of mixed (medical–surgical) ICU patients. Muscle strength at ICU discharge is directly associated with mortality 5 years after discharge [hazard ratio 0.946, 95% CI: 0.928–0.968 per point increase in Medical Research Council (MRC) scores, P = 0.001]. ICUAW serves as umbrella term for the subgroups ‘critical illness myopathy’, ‘critical illness polyneuropathy’, and ‘critical illness polyneuromyopathy’, the latter distinguished using electrophysiology and/or biopsy studies. Diagnosing, studying, and developing treatments for ICUAW among the critically ill seems challenging due to the acuity and severity of the underlying heterogeneous diseases. Ventilator‐induced diaphragmatic dysfunction occurs in up to 80% (n = 32/40) of ICUAW patients after mechanical ventilation and mostly results from distinct muscular pathologies, disuse, underlying critical illness, and/or effects imposed directly by mechanical ventilation. Swallowing disorders/dysphagia likely represent an additional (local) neuromuscular dysfunction/ICUAW sequelae and presents in 10.3% (n = 96/933) of mixed medical–surgical ICU survivors, with 60.4% (n = 58/96) of patients remaining dysphagia positive until hospital discharge. Key independent risk factors for dysphagia following mechanical ventilation are baseline neurological disease [odds ratio (OR) 4.45, 95% CI: 2.74–7.24, P < 0.01], emergency admission (OR 2.04, 95% CI: 1.15–3.59, P < 0.01), days on mechanical ventilation (OR 1.19, 95% CI: 1.06–1.34, P < 0.01), days on renal replacement therapy (OR 1.1, 95% CI: 1–1.23, P = 0.03), and disease severity (Acute Physiology and Chronic Health Evaluation II score within first 24 h; OR 1.03, 95% CI: 0.99–1.07, P < 0.01). Dysphagia positivity independently predicts 28‐day and 90‐day mortality (90‐day univariate hazard ratio: 3.74; 95% CI, 2.01–6.95; P < 0.001) and is associated with a 9.2% excess (all‐cause) mortality rate. CONCLUSIONS: Neuromuscular weakness and muscle wasting is observed in many survivors of critical illness. ICUAW, ventilator‐induced diaphragmatic dysfunction, and dysphagia are associated with complicated and prolonged ICU stay, impaired weaning from mechanical ventilation, impeded rehabilitative measures, and a considerable impact on morbidity and mortality is noted. Future research strategies should further explore underlying pathomechanisms and lead to development of causal treatment strategies.
format Online
Article
Text
id pubmed-7749542
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-77495422020-12-23 Muscular weakness and muscle wasting in the critically ill Schefold, Joerg C. Wollersheim, Tobias Grunow, Julius J. Luedi, Markus M. Z'Graggen, Werner J. Weber‐Carstens, Steffen J Cachexia Sarcopenia Muscle Reviews BACKGROUND: Muscular weakness and/or muscle wasting is recognized as a key medical problem in critically ill patients on intensive care units (ICUs) worldwide. METHODS AND RESULTS: Intensive care unit‐acquired weakness (ICUAW) results from various diseases leading to critical illness and is observed in about 40% [1080/2686 patients, 95% confidence interval (CI): 38–42%] of mixed (medical–surgical) ICU patients. Muscle strength at ICU discharge is directly associated with mortality 5 years after discharge [hazard ratio 0.946, 95% CI: 0.928–0.968 per point increase in Medical Research Council (MRC) scores, P = 0.001]. ICUAW serves as umbrella term for the subgroups ‘critical illness myopathy’, ‘critical illness polyneuropathy’, and ‘critical illness polyneuromyopathy’, the latter distinguished using electrophysiology and/or biopsy studies. Diagnosing, studying, and developing treatments for ICUAW among the critically ill seems challenging due to the acuity and severity of the underlying heterogeneous diseases. Ventilator‐induced diaphragmatic dysfunction occurs in up to 80% (n = 32/40) of ICUAW patients after mechanical ventilation and mostly results from distinct muscular pathologies, disuse, underlying critical illness, and/or effects imposed directly by mechanical ventilation. Swallowing disorders/dysphagia likely represent an additional (local) neuromuscular dysfunction/ICUAW sequelae and presents in 10.3% (n = 96/933) of mixed medical–surgical ICU survivors, with 60.4% (n = 58/96) of patients remaining dysphagia positive until hospital discharge. Key independent risk factors for dysphagia following mechanical ventilation are baseline neurological disease [odds ratio (OR) 4.45, 95% CI: 2.74–7.24, P < 0.01], emergency admission (OR 2.04, 95% CI: 1.15–3.59, P < 0.01), days on mechanical ventilation (OR 1.19, 95% CI: 1.06–1.34, P < 0.01), days on renal replacement therapy (OR 1.1, 95% CI: 1–1.23, P = 0.03), and disease severity (Acute Physiology and Chronic Health Evaluation II score within first 24 h; OR 1.03, 95% CI: 0.99–1.07, P < 0.01). Dysphagia positivity independently predicts 28‐day and 90‐day mortality (90‐day univariate hazard ratio: 3.74; 95% CI, 2.01–6.95; P < 0.001) and is associated with a 9.2% excess (all‐cause) mortality rate. CONCLUSIONS: Neuromuscular weakness and muscle wasting is observed in many survivors of critical illness. ICUAW, ventilator‐induced diaphragmatic dysfunction, and dysphagia are associated with complicated and prolonged ICU stay, impaired weaning from mechanical ventilation, impeded rehabilitative measures, and a considerable impact on morbidity and mortality is noted. Future research strategies should further explore underlying pathomechanisms and lead to development of causal treatment strategies. John Wiley and Sons Inc. 2020-09-07 2020-12 /pmc/articles/PMC7749542/ /pubmed/32893974 http://dx.doi.org/10.1002/jcsm.12620 Text en © 2020 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Schefold, Joerg C.
Wollersheim, Tobias
Grunow, Julius J.
Luedi, Markus M.
Z'Graggen, Werner J.
Weber‐Carstens, Steffen
Muscular weakness and muscle wasting in the critically ill
title Muscular weakness and muscle wasting in the critically ill
title_full Muscular weakness and muscle wasting in the critically ill
title_fullStr Muscular weakness and muscle wasting in the critically ill
title_full_unstemmed Muscular weakness and muscle wasting in the critically ill
title_short Muscular weakness and muscle wasting in the critically ill
title_sort muscular weakness and muscle wasting in the critically ill
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7749542/
https://www.ncbi.nlm.nih.gov/pubmed/32893974
http://dx.doi.org/10.1002/jcsm.12620
work_keys_str_mv AT schefoldjoergc muscularweaknessandmusclewastinginthecriticallyill
AT wollersheimtobias muscularweaknessandmusclewastinginthecriticallyill
AT grunowjuliusj muscularweaknessandmusclewastinginthecriticallyill
AT luedimarkusm muscularweaknessandmusclewastinginthecriticallyill
AT zgraggenwernerj muscularweaknessandmusclewastinginthecriticallyill
AT webercarstenssteffen muscularweaknessandmusclewastinginthecriticallyill